Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    An NIH grant/contract identifier was added to the study's list of Other Study ID Numbers, linking the trial to U.S. NIH funding.
    Difference
    0.0%
    Check dated 2026-08-24T20:02:14.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added contact details for the study locator service, including an email address and phone number, to facilitate outreach and inquiries regarding the study.
    Difference
    0.0%
    Check dated 2026-08-17T16:08:00.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.6.4 to v3.6.5, signaling a newer page version. This is a metadata update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-08-10T14:24:48.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page version rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-07-27T06:18:39.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now shown on the page, replacing v3.6.2, indicating an internal version update to the page metadata.
    Difference
    0.0%
    Check dated 2026-07-05T11:01:19.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.0 to v3.6.2, indicating a newer page version has been published.
    Difference
    0.0%
    Check dated 2026-06-28T08:17:34.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.